BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12740923)

  • 1. Antisense treatment against Ki-67 mRNA inhibits proliferation and tumor growth in vitro and in vivo.
    Kausch I; Lingnau A; Endl E; Sellmann K; Deinert I; Ratliff TL; Jocham D; Sczakiel G; Gerdes J; Böhle A
    Int J Cancer; 2003 Jul; 105(5):710-6. PubMed ID: 12740923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67-directed antisense therapy in an orthotopic renal cell carcinoma model.
    Kausch I; Jiang H; Brocks C; Bruderek K; Krüger S; Sczakiel G; Jocham D; Böhle A
    Eur Urol; 2004 Jul; 46(1):118-24; discussion 124-5. PubMed ID: 15183557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor.
    Eder IE; Hoffmann J; Rogatsch H; Schäfer G; Zopf D; Bartsch G; Klocker H
    Cancer Gene Ther; 2002 Feb; 9(2):117-25. PubMed ID: 11857028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligodeoxynucleotide of glyceraldehyde-3-phosphate dehydrogenase gene inhibits cell proliferation and induces apoptosis in human cervical carcinoma cell lines.
    Kim JW; Kim TE; Kim YK; Kim YW; Kim SJ; Lee JM; Kim IK; Namkoong SE
    Antisense Nucleic Acid Drug Dev; 1999 Dec; 9(6):507-13. PubMed ID: 10645776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I; Jiang H; Ewerdwalbesloh N; Doehn C; Krüger S; Sczakiel G; Jocham D
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides.
    Taylor AH; Pringle JH; Bell SC; Al-Azzawi F
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):219-31. PubMed ID: 11572599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense Ki-67 cDNA transfection reverses the tumorigenicity and induces apoptosis in human breast cancer cells.
    Wang R; Luo D; Ma X; Yang W; Chen R; Liu Y; Meng L; Zhou J; Xu G; Lu YP; Wang S; Ma D
    Cancer Invest; 2008 Oct; 26(8):830-5. PubMed ID: 18798062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ki-67 antisense therapy in murine renal cell carcinoma models].
    Kausch I; Jiang H; Brocks C; Albers A; Krüger S; Sczakiel G; Jocham D
    Aktuelle Urol; 2005 Apr; 36(2):142-8. PubMed ID: 15902575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of apoptosis, tumorigenesity and metastatic potential with antisense H-ras oligodeoxynucleotides in a high metastatic tumor model of hepatoma: LCI-D20.
    Liao Y; Tang ZY; Ye SL; Liu KD; Sun FX; Huang Z
    Hepatogastroenterology; 2000; 47(32):365-70. PubMed ID: 10791191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumor growth using antisense oligonucleotide against survivin in an orthotopic transplant model of human hepatocellular carcinoma in nude mice.
    Sun Y; Lin R; Dai J; Jin D; Wang SQ
    Oligonucleotides; 2006; 16(4):365-74. PubMed ID: 17155911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
    Yang DC; Jiang X; Elliott RL; Head JF
    Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of LncaP prostate cancer cells by means of androgen receptor antisense oligonucleotides.
    Eder IE; Culig Z; Ramoner R; Thurnher M; Putz T; Nessler-Menardi C; Tiefenthaler M; Bartsch G; Klocker H
    Cancer Gene Ther; 2000 Jul; 7(7):997-1007. PubMed ID: 10917202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense DNAs as multisite genomic modulators identified by DNA microarray.
    Cho YS; Kim MK; Cheadle C; Neary C; Becker KG; Cho-Chung YS
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9819-23. PubMed ID: 11481453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro and in vivo evaluation of inhibitory nucleic acid constructs for specific therapy of human urinary bladder carcinoma].
    Kunze D; Füssel S; Meye A; Wuttig D; Krämer K; Kotzsch M; Toma M; Schwenzer B; Kausch I; Jocham D; Hakenberg OW; Grimm MO; Wirth MP
    Urologe A; 2007 Sep; 46(9):1289. PubMed ID: 17665160
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity.
    Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV
    Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of renal cancer cell growth in vitro and in vivo with oncolytic adenovirus armed short hairpin RNA targeting Ki-67 encoding mRNA.
    Zheng JN; Pei DS; Mao LJ; Liu XY; Mei DD; Zhang BF; Shi Z; Wen RM; Sun XQ
    Cancer Gene Ther; 2009 Jan; 16(1):20-32. PubMed ID: 18690204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.
    Chuang CK; Liao SK
    Anticancer Res; 2000; 20(2A):749-60. PubMed ID: 10810350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
    Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.